Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Ibogamine congeners for addiction

April 15, 1997

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Antineoplastic cryptophycin compounds

April 15, 1997

Novel dopamine receptor ligands from Purdue Research Foundation/UNC

April 15, 1997

ICE and apoptosis inhibitors disclosed by SmithKline Beecham

April 15, 1997

Use of desbutylhalofantrine for malaria claimed

April 15, 1997

Novartis describes small-molecule signal transduction inhibitors

April 14, 1997

Takeda reveals endothelin antagonists

April 14, 1997

Orally active GH secretagogues reported by Lilly

April 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...